Caribbean Petroleum Accident- CSB to hold public meeting to finalize report

Spread the love

Oct 20, 2015 Washington DC– The US Chemical Safety Board (CSB) will convene a public meeting on October 21, 2015, starting at 1 p.m. EDT in Washington, DC at the Palomar Hotel, 2121 P St, NW, in the Phillips Ballroom.

The Board will discuss the final report and recommendations from the Caribbean Petroleum incident. The Board may then vote on the Caribbean Petroleum report. For more information on the incident please see our blog post here . The root cause of the Caribbean Petroleum accident, was found to be faulty level indications, as given in our report here. Incidentally, this is the same root cause as that in the Buncefield incident.

The Board will also discuss the status of several current CSB investigations, including ExxonMobil Torrance, West Fertilizer, Freedom Industries, DuPont LaPorte, Macondo (the BP Deepwater Horizon accident), and Williams Olefins. And the Board will discuss the agency action plan for FY 15 in addition to the newly confirmed Chairperson’s overview of her first 60 days.

An opportunity for public comment will be provided. Those unable to attend the meeting in person, may submit public comments via email to

The meeting is free and open to the public. This meeting will be webcast for those who cannot attend in person. Please visit on Monday October 19, 2015, for information about the live webcast.

The CSB is an independent federal agency charged with investigating accidents and hazards that result, or may result, in the catastrophic release of extremely hazardous substances. The agency’s Board Members are appointed by the President and confirmed by the Senate. CSB investigations look into all aspects of chemical accidents and hazards, including physical causes such as equipment failure as well as inadequacies in regulations, industry standards, and safety management systems.

For further Information please see the Federal Register Notice or contact Shauna Lawhorne, Public Affairs Specialist, or (202) 384-2839.